Mapping Nanoscale Protein‐Corona Kinetics of DoE‐Optimized Perfluorocarbon Encapsulated‐PLGA Nanoparticles by In Situ, Time‐Resolved Synchrotron SAXS
Advanced Healthcare Materials · 2026-05 · 15 (20)
DOI: 10.1002/adhm.202505091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 22.03.2026. Verfasst von Joice Maria Joseph und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Camerino, Camerino, Italy. Hauptthemen laut MEDLINE: Nanoparticles, X-Ray Diffraction, Fluorocarbons, Polyglycolic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie Skłodowska-Curie.
Abstract (Originalsprache)
Integrated frameworks that couple statistically guided formulation with nanoscale, time‐resolved mapping of the protein corona (PC) remain rare for perfluoro‐15‐crown‐5‐ether‐loaded poly(lactic ‐co‐ glycolic acid) nanoparticles (PFCE‐PLGA NPs). We apply a two‐phase workflow: a single‐factor screen of PLGA/surfactant molecular‐weight ( Mw ) pairings under homogenization versus probe sonication; and a central composite design varying sonication time, surfactant concentration, and PFCE volume to model effects on size, polydispersity index), zeta (ζ)‐potential, loading capacity (LC), and fluorine signal‐to‐noise ratio. Scanning electron microscopy and transmission electron microscopy confirm spherical morphology of the NPs. Synchrotron small‐angle X‐ray scattering (SAXS) first resolves PFCE‐dependent internal NP structure and then, in situ and time‐resolved, tracks corona evolution across physiologic albumin levels (40, 20, and 2 mg mL −1 ), quantifying shell thickness, protein volume fraction, and polydispersity while distinguishing PFCE‐PLGA from blank PLGA NPs. Fibroblast assays show no significant cytotoxicity at tested doses. Overall, combining design‐of‐experiments with in situ SAXS links processing variables to nanoscale structure and protein‐mediated transformations, guiding rational PFCE‐PLGA NP design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Camerino, Camerino, Italy.
- Department of Pharmacy, University of "G. D'Annunzio" Chieti and Pescara, Chieti, Italy.
- Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.
- Department of Biomedical and Neuromotor Sciences (DIBINEM), Section of Human Anatomy, University of Bologna, Bologna, Italy.
ORCID-Profile: Maria Rosa Gigliobianco
Förderung
- Marie Skłodowska-Curie
Zitieren
APA
Maria Joseph, J., Gigliobianco, M. R., Minnelli, C., Moretti, P., Spinozzi, F., Mobbili, G., Pistolesi, S., Casadidio, C., Teti, G., Censi, R., Gattone, S. A., & Di Martino, P. (2026). Mapping Nanoscale Protein‐Corona Kinetics of DoE‐Optimized Perfluorocarbon Encapsulated‐PLGA Nanoparticles by In Situ, Time‐Resolved Synchrotron SAXS. Advanced Healthcare Materials, 15(20). https://doi.org/10.1002/adhm.202505091
Vancouver
Maria Joseph J, Gigliobianco MR, Minnelli C, Moretti P, Spinozzi F, Mobbili G, et al. Mapping Nanoscale Protein‐Corona Kinetics of DoE‐Optimized Perfluorocarbon Encapsulated‐PLGA Nanoparticles by In Situ, Time‐Resolved Synchrotron SAXS. Advanced Healthcare Materials. 2026;15(20). doi:10.1002/adhm.202505091
BibTeX
@article{MariaJoseph2026,
author = {Maria Joseph, Joice and Gigliobianco, Maria Rosa and Minnelli, Cristina and Moretti, Paolo and Spinozzi, Francesco and Mobbili, Giovanna and Pistolesi, Sara and Casadidio, Cristina and Teti, Gabriella and Censi, Roberta and Gattone, Stefano Antonio and Di Martino, Piera},
title = {Mapping Nanoscale Protein‐Corona Kinetics of DoE‐Optimized Perfluorocarbon Encapsulated‐PLGA Nanoparticles by In Situ, Time‐Resolved Synchrotron SAXS},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {20},
doi = {10.1002/adhm.202505091}
}
EUVIMED